(Q43542416)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Effects of clodronate on vertebral fracture risk in osteoporosis: a 1-year interim analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

E McCloskey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D de Takats

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Bernard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Davies

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Robinson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Francis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Adams

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Pande

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Beneton

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Jalava

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Löyttyniemi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J A Kanis

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

310-315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Esophagitis associated with the use of alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Long term effects of dichloromethylene diphosphonate in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long-term clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Effects of one-year cyclical treatment with clodronate on postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

The influence of dichloromethylene bisphosphonate on the healing of a long bone fracture, composition of bone mineral and histology of bone in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Clodronate decreases the frequency of skeletal metastases in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

The effects of clodronate on increased bone turnover and bone loss due to ovariectomy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

The influence of clodronate on the torsional strength of the growing rat tibia in immobilization osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

The assessment of vertebral deformity: a method for use in population studies and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

European semi-anthropomorphic spine phantom for the calibration of bone densitometers: assessment of precision, stability and accuracy. The European Quantitation of Osteoporosis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Effect of alendronate on fracture healing and bone remodeling in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Intramuscular clodronate therapy in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Effect of clodronate on fracture healing in denervated rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900437-3

7 January 2021

10.1016/S8756-3282(00)00437-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11248662%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference